DNA mismatch repair-deficient(dMMR)/microsatellite instability-high(MSI-H) colorectal adenocarcinoma has a high sensitivity to immunotherapy and has been approved for anti-PD-1/PD-L1 immunotherapy. This evidence concerns the gene CD274 and colorectal adenocarcinoma.